NCT03338816 · Interventional trial
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
Overall registry status Completed
Phase 3
Conditions ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Hereditary Coproporphyria (HCP), Porphyria, Acute Intermittent, Variegate Porphyria (VP)
Delaware Valley sites
- Clinical Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory